Skip to content

Clinical trials

Phase 3 Heart Defects, Congenital trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Defects, Congenital Phase: Phase 3 Country / region: United States Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20032
20042
20063
20091
20121
20141
20172
20211
20221
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting2
Unknown status2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Mayo Clinic2
National Heart, Lung, and Blood Institute (NHLBI)2
Sanofi2
Actelion1
Asklepion Pharmaceuticals, LLC1
Carelon Research1
Children's Hospital Medical Center, Cincinnati1
Children's National Research Institute1
Encysive Pharmaceuticals1
Mallinckrodt1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Defects, Congenital19
Heart Failure2
Hypertension, Pulmonary2
Hypoplastic Left Heart Syndrome2
Thrombosis2
Acute Kidney Injury1
Acute Lung Injury1
Cardiomyopathies1
Cardiovascular Diseases1
Connective Tissue Diseases1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.